Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Dupuis · SciRah

Researcher profile · Semantic Scholar

J. Dupuis

Share profile

J. Dupuis — researcher profile on SciRah

h-index: 46
Works: 224
Citations: 7,758

Most-cited papers

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Michael L. Wang, S. Rule, P. Zinzani, A. Goy +25 more
2017The Lancet410 citations Open access
Semantic Scholar
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
R. Casasnovas, R. Bouabdallah, P. Brice, J. Lazarovici +26 more
2019The Lancet Oncology175 citations Open access
Semantic Scholar
Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.
F. Lemonnier, J. Dupuis, P. Sujobert, Olivier Tournillhac +10 more
2018Blood168 citations
Semantic Scholar
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.
M. Delfau-Larue, A. Van Der Gucht, J. Dupuis, J. Jais +12 more
2018Blood Advances122 citations Open access
Semantic Scholar
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
C. Rossi, J. Gilhodes, M. Maerevoet, C. Herbaux +22 more
2018American journal of hematology/oncology104 citations Open access
Semantic Scholar
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Michael L. Wang, S. Rule, P. Zinzani, A. Goy +23 more
2019Leukemia91 citations Open access
Semantic Scholar
Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association
C. Sarkozy, T. Molina, H. Ghesquières, A. Michallet +16 more
2017Haematologica70 citations Open access
Semantic Scholar
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)
K. Laribi, S. Poulain, L. Willems, F. Merabet +13 more
2018British Journal of Haematology67 citations Open access
Semantic Scholar
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.
A. Cottereau, A. Versari, S. Luminari, J. Dupuis +11 more
2018Blood64 citations Open access
Semantic Scholar
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi‐institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
E. Durot, C. Tomowiak, A. Michallet, J. Dupuis +18 more
2017British Journal of Haematology55 citations
Semantic Scholar
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
M. André, P. Carde, S. Viviani, M. Bellei +18 more
2020Cancer Medicine52 citations Open access
Semantic Scholar
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
J. Paillassa, E. Cornet, S. Noel, C. Tomowiak +32 more
2020Blood Cancer Journal52 citations Open access
Semantic Scholar
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients
Anne Wanquet, R. Birsen, C. Bonnet, M. Boubaya +16 more
2017British Journal of Haematology47 citations Open access
Semantic Scholar
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
R. Gressin, N. Daguindau, A. Tempescul, A. Moreau +36 more
2018Haematologica45 citations Open access
Semantic Scholar
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation
C. Cazelles, K. Belhadj, H. Vellemans, V. Camus +15 more
2021Leukemia and Lymphoma43 citations Open access
Semantic Scholar
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
J. Dupuis, E. Bachy, Franck Morschhauser, G. Cartron +24 more
2024The Lancet Haematology35 citations Open access
Semantic Scholar
Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study
R. Casasnovas, R. Bouabdallah, P. Brice, J. Lazarovici +20 more
2022Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort
F. Bouclet, A. Calleja, M. Dilhuydy, L. Véronèse +22 more
2021Annals of Hematology32 citations
Semantic Scholar
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma
B. Rousseau, Aude Guillemin, C. Duvoux, C. Neuzillet +14 more
2018International Journal of Cancer32 citations Open access
Semantic Scholar
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
C. Herbaux, C. Kornauth, S. Poulain, Stephen J. F. Chong +22 more
2021Blood30 citations Open access
Semantic Scholar
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
I. Demeestere, J. Racapé, J. Dechène, J. Dupuis +17 more
2021Journal of Clinical Oncology30 citations Open access
Semantic Scholar
Real‐world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients
L. Ysebaert, T. Aurran-Schleinitz, C. Dartigeas, M. Dilhuydy +7 more
2017American journal of hematology/oncology29 citations Open access
Semantic Scholar
Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma
É. Crickx, E. Poullot, G. Moulis, R. Goulabchand +18 more
2019European Journal of Haematology26 citations
Semantic Scholar
Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Michael L. Wang, S. Rule, P. Zinzani, A. Goy +23 more
2018Clinical Lymphoma, Myeloma & Leukemia25 citations Open access
Semantic Scholar
Upfront Carfilzomib, Lenalidomide, Dexamethasone with Transplant in Multiple Myeloma Patients, the IFM KRd final results.
M. Roussel, V. Lauwers-Cancès, S. Wuillème, K. Belhadj +15 more
2021Blood23 citations
Semantic Scholar
miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study
Anne-Laure Gagez, I. Duroux-Richard, S. Leprêtre, F. Orsini-Piocelle +12 more
2017Haematologica23 citations Open access
Semantic Scholar
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
A. Quinquenel, Sophie Godet, C. Dartigeas, L. Ysebaert +18 more
2019American journal of hematology/oncology22 citations Open access
Semantic Scholar
Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.
A. Rentien, Michaël Lévy, C. Copie-Bergman, C. Gagnière +7 more
2017Digestive and Liver Disease22 citations
Semantic Scholar
Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma
A. Amiot, V. Jooste, C. Gagnière, Michaël Lévy +8 more
2017Leukemia and Lymphoma21 citations
Semantic Scholar
Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)
K. Laribi, S. Poulain, L. Willems, F. Merabet +10 more
2024British Journal of Haematology20 citations
Semantic Scholar
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
E. Durot, L. Kanagaratnam, S. Zanwar, E. Kastritis +22 more
2020Haematologica20 citations Open access
Semantic Scholar
Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study
J. Dupuis, K. Tsukasaki, E. Bachy, F. Morschhauser +18 more
2022Blood19 citations Open access
Semantic Scholar
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis
Hélène Pasquer, K. Belhadj, J. Dupuis, S. Oghina +12 more
2021British Journal of Haematology18 citations
Semantic Scholar
Genetic Characterization and Clinical Features of Helicobacter pylori Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
B. Kiesewetter, C. Copie-Bergman, Michaël Lévy, Fang-Tian Wu +18 more
2021Cancers17 citations Open access
Semantic Scholar
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis.
F. Le Bras, V. Molinier-Frenkel, A. Guellich, J. Dupuis +9 more
2017European Journal of Cancer17 citations
Semantic Scholar
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
C. Rossi, M. André, J. Dupuis, F. Morschhauser +19 more
2022Haematologica15 citations Open access
Semantic Scholar
Colonic mucosa-associated lymphoid tissue lymphoma: a case series
J. Tannoury, A. Amiot, F. Lemonnier, J. Dupuis +7 more
2019Leukemia and Lymphoma15 citations
Semantic Scholar
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
A. Michallet, A. Campidelli, Hélène Lequeu, M. Dilhuydy +12 more
2017American journal of hematology/oncology15 citations Open access
Semantic Scholar
Randomized phase III study comparing an early PET driven treatment de-escalation to a not PET-monitored strategy in patients with advanced stages Hodgkin lymphoma: Final analysis of the AHL2011 LYSA study.
O. Casasnovas, P. Brice, R. Bouabdallah, G. Salles +16 more
201813 citations
Semantic Scholar
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies
S. B. Gressens, S. Fourati, A. Le Bouter, F. Le Bras +10 more
2022Clinical Microbiology and Infection12 citations Open access
Semantic Scholar
Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Long-Term Efficacy and Safety Results from a Phase 2 Study
Michael L. Wang, S. Rule, P. Zinzani, A. Goy +21 more
2020Blood12 citations
Semantic Scholar
Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis
T. Lamy, C. Pastoret, R. Houot, L. Ysebaert +16 more
2019Blood11 citations Open access
Semantic Scholar
Total Metabolic Tumor Volume and Tumor Dissemination Are Independent Prognostic Factors in Advanced Hodgkin Lymphoma
S. Kanoun, A. Berriolo-Riedinger, A. Cottereau, V. Edeline +13 more
2021Blood10 citations Open access
Semantic Scholar
Venetoclax induces sustained complete responses in refractory/relapsed patients with cardiac AL amyloidosis.
F. Le Bras, J. Dupuis, F. Lemonnier, S. Oghina +9 more
2019Journal of Clinical Oncology10 citations
Semantic Scholar
Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study
G. Cartron, R. Letestu, C. Dartigeas, M. Tout +18 more
2018Haematologica10 citations Open access
Semantic Scholar
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
E. Durot, L. Kanagaratnam, S. Zanwar, E. Toussaint +25 more
2022Blood Advances9 citations Open access
Semantic Scholar
Lymphomatoid papulosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: three cases
H. Adamski, S. Ingen-Housz-Oro, L. Machet, A. Carriou +9 more
2018British Journal of Dermatology8 citations
Semantic Scholar
Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies
S. B. Gressens, A. Wiedemann, Marie Déchenaud, J. Dupuis +5 more
2023Vaccine7 citations Open access
Semantic Scholar
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment
R. Gounot, F. Le Bras, J. Dupuis, S. Oghina +11 more
2020Leukemia and Lymphoma7 citations
Semantic Scholar
Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study
Michael L. Wang, S. Rule, P. Zinzani, A. Goy +24 more
20177 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Morschhauser×13
Invite
F. Morschhauser — researcher profile on SciRah
R. Casasnovas×12
Invite
R. Casasnovas — researcher profile on SciRah
P. Feugier×11
Invite
P. Feugier — researcher profile on SciRah
C. Haioun×11
Invite
C. Haioun — researcher profile on SciRah

×9

Invite

A. Delmer — researcher profile on SciRah

Invite

L. Ysebaert — researcher profile on SciRah

S. Leprêtre×9

Invite

S. Leprêtre — researcher profile on SciRah

Invite

K. Belhadj — researcher profile on SciRah

Invite

T. Lamy — researcher profile on SciRah

F. Lemonnier×8

Invite

F. Lemonnier — researcher profile on SciRah

A. Michallet×8

Invite

A. Michallet — researcher profile on SciRah

Invite

F. Le Bras — researcher profile on SciRah